Cargando…
Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells
Because dendritic cells are crucial to prime and expand antigen-specific CD8(+) T-cells, several strategies are designed to use them in therapeutic vaccines against infectious diseases or cancer. In this context, off-the-shelf allogeneic dendritic cell-based platforms are more attractive than indivi...
Autores principales: | Lenogue, Kevin, Walencik, Alexandre, Laulagnier, Karine, Molens, Jean-Paul, Benlalam, Houssem, Dreno, Brigitte, Coulie, Pierre, Pule, Martin, Chaperot, Laurence, Plumas, Joël |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916617/ https://www.ncbi.nlm.nih.gov/pubmed/33578850 http://dx.doi.org/10.3390/vaccines9020141 |
Ejemplares similares
-
Plasmacytoid Dendritic Cells Capture and Cross-Present Viral Antigens from Influenza-Virus Exposed Cells
por: Lui, Gabrielle, et al.
Publicado: (2009) -
An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial
por: Charles, Julie, et al.
Publicado: (2020) -
Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines
por: Hannani, Dalil, et al.
Publicado: (2023) -
A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients
por: Hannani, Dalil, et al.
Publicado: (2023) -
Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation
por: Veron, Philippe, et al.
Publicado: (2009)